CrossrefInfokarte
Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies
Pathophysiology · 2018-12 · 25 (4) · 327-333
DOI: 10.1016/j.pathophys.2018.05.003 ↗Abstract
Kein Abstract verfügbar.
EUVIMED